Article
Histologic transformation of epidermal growth factor receptor-mutated lung cancer.
European journal of cancer (Oxford, England : 1990) - 1 May 2022
Fujimoto Daichi, Akamatsu Hiroaki, Morimoto Takeshi, Wakuda Kazushige, Sato Yuki, Kawa Yoshitaka, Yokoyama Toshihide, Tamiya Motohiro, Hiraoka Ryota, Shingu Naoki, Ikeda Hideki, Tamiya Akihiro, Kanazu Masaki, Miyauchi Eisaku, Miura Satoru, Yanai Masaaki, Yomota Makiko, Morinaga Ryotaro, Yokoi Takashi, Hata Akito, Suzuki Hidekazu, Matsumoto Hirotaka, Sakata Shinya, Furuya Naoki, Harutani Yuhei, Nakachi Ichiro, Otsuki Ayumu, Uematsu Shinya, Hara Satoshi, Yokoo Keiki, Sugimoto Takeya, Yamamoto Nobuyuki
Abstract excerpt
PURPOSE: This study aimed to determine the incidence and clinical course of epidermal growth factor receptor (EGFR)-mutated lung cancer with histologic transformation (HT). PATIENTS AND METHODS: We conducted a multicentre, retrospective, cohort study of patients with advanced EGFR-mutated lung cancer who received EGFR-tyrosine kinase inhibitors (TKIs) between 2012 and 2019. The primary outcome was the incidence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
